bioRxivGenomicsPreprint
HyperCas12a enables multiplexed CRISPRi screens
Schuyler M. MeloreiD, Christian McRoberts AmadoriD, Marisa C. HamiltoniD, Charles A. GersbachiD, Timothy E. ReddyiD
Abstract
Interactions between multiple genes or cis-regulatory elements (CREs) underlie a wide range of biological processes in both health and disease. High-throughput screens using dCas9 fused to epigenome editing domains have allowed researchers to assess the impact of activation or repression of both coding and non-coding genomic regions on a phenotype of interest, but assessment of genetic interactions between those elements has been limited to pairs. Here, we combine a hyper-efficient version of Lachnospiraceae bacterium dCas12a (dHyperLbCas12a) with RNA Polymerase II expression of long CRISPR RNA (crRNA) arrays to enable efficient highly-multiplexed epigenome editing. We demonstrate that this system is compatible with several activation and repression domains, including the P300 histone acetyltransferase domain and SIN3A interacting domain (SID). We further show that the system can be used in cultured primary immune cells and to drive differentiation of induced pluripotent stem cells. We also developed new approaches to use the dCas12a platform for simultaneous activation and repression from a single crRNA array via co-expression of multiple dCas12a orthologues. Lastly, we demonstrate that the dHyperLbCas12a effectors are highly effective for multiple modalities of high-throughput screens, namely proliferation screens and screens to dissect the independent and combinatorial contributions of CREs on gene expression. The tools and methods introduced here create new possibilities for highly multiplexed control of gene expression in a wide variety of biological systems.
- Citations
- 3
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Multiplexed activation in mammalian cells using dFnCas12a-VPR
James W. Bryson, Jamie Auxillos, Susan J. Rosser·Nucleic Acids ResearchPeer-reviewed·Nov 26, 2021
- Higher-order combinatorial chromatin perturbations by engineered CRISPR-Cas12a for functional genomics
Chris C.‐S. Hsiung, Caroline M. Wilson, … Luke A. Gilbert·Nature BiotechnologyPeer-reviewed·May 17, 2024
- Optimization of Cas12a for multiplexed genome-scale transcriptional activation
Audrey L Griffith, Fengyi Zheng, … John G. Doench·Cell GenomicsPeer-reviewed·Sep 1, 2023
- Interrogation of Enhancer Function by Enhanced CRISPR Epigenetic Editing
Kailong Li, Yuxuan Liu, … Jian Xu·bioRxiv·Sep 8, 2019
- High-fidelity enhanced AsCas12a knock-in mice for efficient multiplexed gene editing, disease modeling and orthogonal immunogenetics
Kaiyuan Tang, Xiaoyu Zhou, … Sidi Chen·bioRxiv·Mar 14, 2024
- Transgenic mice for in vivo epigenome editing with CRISPR-based systems
Matthew P. Gemberling, Keith Siklenka, … Charles A. Gersbach·bioRxiv·Mar 8, 2021